Teva prices EpiPen generic at $300, same price as Mylan generic
Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst | Fierce Pharma
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Mylan vs. Teva: Which Is the Better Generics Stock Ahead of Earnings?
Teva, Mylan to jumpstart production of old malaria drug to fight coronavirus
How Mylan tried to keep Teva from selling a generic EpiPen
Why Is This Generic Manufacturer Being Trampled by Its Industry Rivals? | The Motley Fool
Teva makes $40 billion offer for Mylan
Mylan vs. Teva: Which Is the Better Generics Stock Ahead of Earnings?
Mylan, Generic Copaxone Punish Teva (NYSE:TEVA) | Seeking Alpha
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Teva makes $40.1 billion takeover bid for Mylan | Mint
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare IT News
Generic EpiPen by Teva Wins FDA Nod After 2 Year Delay | Fierce Pharma
Lawmakers accuse drugmakers Mylan, Teva of 'coordinated obstruction'
Teva settles litigation with Mylan over Nuvigil - Pharmaceutical Technology
The Teva vs. Mylan drug war - The Jerusalem Post
Teva Offers to Buy Mylan for $40 Billion - WSJ
Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats | Fierce Pharma
Teva shares rival Mylan's pain as both hit two-year lows | Fierce Pharma
Therapeutically equivalent to EpiPen®
Mylan/Viatris and Teva at the 38th Annual J.P. Morgan Healthcare Conference - MidgardFinance.com
$40B deal: Teva offers to buy Mylan
Mylan Teva EpiPen Generic Auto-Injector Market
FDA Approves Teva's Generic EpiPen As Stock Rises
Teva Launches Site for Generic EpiPen Equivalent | SnackSafely.com
